MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer

Charis Kalogirou(Universitätsklinikum Würzburg), Almut Schulze(German Cancer Research Center)
Nature Communications
August 20, 2021
Cited by 73


Related Papers